Department of Neuropharmacology, Institute of Nautical Medicine, Nantong University, Nantong, 226001, China.
Neurosci Bull. 2012 Oct;28(5):550-60. doi: 10.1007/s12264-012-1266-y. Epub 2012 Sep 12.
Glycine acts as a co-agonist for the activation of N-methyl-D-aspartate receptors (NMDARs) by binding to glycine sites, thus potentiating glutamate-elicited responses and inhibiting NMDAR desensitization in a dose-dependent manner. The present study aimed to characterize the glycine-dependent inactivation of NMDARs and to explore its pathophysiological significance.
Primary hippocampal cell cultures from embryonic days 17-18 rats were treated with NMDA or NMDA plus glycine. Patch-clamp recording and intracellular Ca(2+) imaging were performed to test the effects of glycine on NMDA-activated currents and increase of intracellular free Ca(2+) respectively. Immunofluorescence staining was conducted to examine NR1 internalization. Cell damage was tested with MTT method and lactate dehydrogenase leakage.
Glycine reduced the peak current and Ca(2+) influx elicited by NMDA application at concentrations ≥ 300 μmol/L. This is a novel suppressive influence of glycine on NMDAR function, since it occurs via the NMDAR glycine-binding site, in contrast to the classic suppression, which occurs through the binding of glycine to glycine receptors. The level of membrane NMDARs was measured to evaluate whether internalization was involved. Immunohistochemical labeling showed that incubation with high concentrations of NMDA plus glycine did not change the expression of NMDARs on the cell surface when compared to the expression without glycine; hence the possibility of NMDAR internalization primed by glycine binding was excluded.
In summary, the novel suppressive effect of glycine on NMDARs was mediated via binding to the glycine site of the NMDAR and not by activation of the strychnine-sensitive glycine-receptor-gated chloride channel or by the internalization of NMDARs. The inhibitory influence of glycine on NMDARs adds a new insight to our knowledge of the complexity of synaptic transmission.
甘氨酸通过与甘氨酸结合位点结合,作为 N-甲基-D-天冬氨酸受体(NMDAR)的共激动剂发挥作用,从而以剂量依赖的方式增强谷氨酸引发的反应并抑制 NMDAR 脱敏。本研究旨在描述甘氨酸依赖性 NMDAR 失活,并探讨其病理生理意义。
用 NMDA 或 NMDA 加甘氨酸处理来自胚胎第 17-18 天大鼠的原代海马细胞培养物。进行膜片钳记录和细胞内 Ca(2+)成像,分别测试甘氨酸对 NMDA 激活电流和细胞内游离 Ca(2+)增加的影响。进行免疫荧光染色以检查 NR1 内化。用 MTT 法和乳酸脱氢酶渗漏检测细胞损伤。
甘氨酸在浓度≥300μmol/L 时降低 NMDA 应用引起的峰值电流和 Ca(2+)内流。与经典抑制作用相反,这是甘氨酸对 NMDAR 功能的一种新的抑制作用,因为它通过 NMDAR 甘氨酸结合位点发生,而经典抑制作用通过甘氨酸与甘氨酸受体结合发生。测量膜 NMDAR 的水平以评估是否涉及内化。免疫组织化学标记显示,与无甘氨酸相比,用高浓度 NMDA 加甘氨酸孵育不会改变细胞表面 NMDAR 的表达;因此排除了甘氨酸结合引发的 NMDAR 内化的可能性。
总之,甘氨酸对 NMDAR 的新型抑制作用是通过与 NMDAR 的甘氨酸结合位点结合而介导的,而不是通过激活士的宁敏感甘氨酸受体门控氯离子通道或通过 NMDAR 的内化来介导。甘氨酸对 NMDAR 的抑制作用为我们对突触传递复杂性的认识增添了新的见解。